- Home
- BILI vs TXMD Comparison
BILI vs TXMD Comparison
Compare BILI & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BILI
- TXMD
- Stock Information
- Founded
- BILI 2009
- TXMD 2008
- Country
- BILI China
- TXMD United States
- Employees
- BILI N/A
- TXMD N/A
- Industry
- BILI EDP Services
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- BILI Technology
- TXMD Health Care
- Exchange
- BILI Nasdaq
- TXMD Nasdaq
- Market Cap
- BILI 8.8B
- TXMD 12.7M
- IPO Year
- BILI 2018
- TXMD N/A
- Fundamental
- Price
- BILI $28.02
- TXMD $1.06
- Analyst Decision
- BILI Buy
- TXMD
- Analyst Count
- BILI 6
- TXMD 0
- Target Price
- BILI $26.00
- TXMD N/A
- AVG Volume (30 Days)
- BILI 4.0M
- TXMD 17.5K
- Earning Date
- BILI 11-13-2025
- TXMD 11-11-2025
- Dividend Yield
- BILI N/A
- TXMD N/A
- EPS Growth
- BILI N/A
- TXMD N/A
- EPS
- BILI 0.07
- TXMD N/A
- Revenue
- BILI $4,101,275,719.00
- TXMD $2,559,000.00
- Revenue This Year
- BILI $14.58
- TXMD $427.09
- Revenue Next Year
- BILI $8.92
- TXMD N/A
- P/E Ratio
- BILI $384.73
- TXMD N/A
- Revenue Growth
- BILI 22.70
- TXMD 156.93
- 52 Week Low
- BILI $14.47
- TXMD $0.70
- 52 Week High
- BILI $31.77
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- BILI 73.49
- TXMD 40.43
- Support Level
- BILI $23.70
- TXMD $1.06
- Resistance Level
- BILI $27.64
- TXMD $1.14
- Average True Range (ATR)
- BILI 0.74
- TXMD 0.05
- MACD
- BILI 0.53
- TXMD -0.00
- Stochastic Oscillator
- BILI 97.09
- TXMD 5.26
About BILI Bilibili Inc.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.